We are live on
!
Find out more
1WCM
12 West Capital Management Portfolio holdings
AUM
$535M
1-Year Est. Return
25.99%
This Fund
S&P 500
This Quarter
Est. Return
+2.83%
1 Year Est. Return
+25.99%
3 Year Est. Return
+168.87%
5 Year Est. Return
+90.56%
10 Year Est. Return
+1,084.81%
AUM
$1.13B
AUM Growth
-$40.2M
(-3.4%)
Cap. Flow
+$13.7M
Cap. Flow
% of AUM
1.21%
Top 10 Holdings %
Top 10 Hldgs %
84.23%
Holding
23
New
1
Increased
5
Reduced
5
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SMAR
Smartsheet Inc.
SMAR
|
+$26.6M |
| 2 |
Toast
TOST
|
+$25.3M |
| 3 |
AppFolio
APPF
|
+$22.3M |
| 4 |
Bio-Techne
TECH
|
+$18.2M |
| 5 |
Roblox
RBLX
|
+$14.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
10x Genomics
TXG
|
+$56.5M |
| 2 |
nCino
NCNO
|
+$12.4M |
| 3 |
Affirm
AFRM
|
+$8.13M |
| 4 |
Sprout Social
SPT
|
+$6.61M |
| 5 |
GDS Holdings
GDS
|
+$5.73M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 60.44% |
| 2 | Healthcare | 15.43% |
| 3 | Consumer Discretionary | 12.04% |
| 4 | Communication Services | 9.69% |
| 5 | Miscellaneous | 2.39% |
Similar funds
SDAM
MWP
CWM
SCP
BCM
S
WMG
RCI
12 West Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, 12 West Capital Management held 23 positions worth $1.13B, down 3.4% from $1.17B the previous quarter. Its ten largest holdings account for 84% of the portfolio.
12 West Capital Management's Q3 2022 filing shows 1 new, 5 increased, 5 reduced and 3 closed positions. Its largest new stake was Bio-Techne: 210,592 shares worth $15M. The largest sale was 10x Genomics, an estimated $56.5M.
By sector, the portfolio is most concentrated in Technology at 60% of assets, up from 60% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- 12 West Capital Management's largest Q3 2022 buy was Bio-Techne: 210,592 shares worth $15M.
- 12 West Capital Management added most to Smartsheet Inc. in Q3 2022, an estimated $26.6M increase.
- 12 West Capital Management's biggest Q3 2022 reduction was Sprout Social, cutting an estimated $6.61M.
- 12 West Capital Management fully exited 10x Genomics in Q3 2022, selling an estimated $56.5M.
- 12 West Capital Management's ten largest holdings make up 84% of its $1.13B portfolio in Q3 2022.
- 12 West Capital Management opened 1 new position and closed 3 in Q3 2022.
- 12 West Capital Management's portfolio value fell 3.4% quarter-over-quarter to $1.13B.
Based on 12 West Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.